Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00084344 · ClinicalTrials.gov registry record · NA
Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
NCT00084344 is a NA study that has completed, run by Northwestern University.
The verdict
NCT00084344, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
RATIONALE: High estrogen levels may be associated with dense breast tissue and an increased risk of developing breast cancer. 4-hydroxytamoxifen gel (a substance made when tamoxifen breaks down in the body) may be effective in reducing breast density by reducing estrogen levels with fewer side effects than tamoxifen. This may improve quality of life and the ability to detect breast cancer with screening mammography. PURPOSE: Randomized screening study to determine the effect of 4-hydroxytamoxifen gel on breast density, salivary sex steroids (hormones), and quality of life in premenopausal women.
Interventions
- PROCEDURE breast imaging study
- PROCEDURE radiomammography
- DRUG 4-hydroxytamoxifen
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-04 |
| Est. Completion | 2004-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00084344
The ClinicalTrials.gov registry entry for NCT00084344 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which breast imaging study is the first listed.
NCT00084344 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00084344 about?
NCT00084344 is a clinical study titled "Effect of 4-Hydroxytamoxifen Gel on Breast Density, Salivary Sex Steroids, and Quality of Life in Premenopausal Women". RATIONALE: High estrogen levels may be associated with dense breast tissue and an increased risk of developing breast cancer. 4-hydroxytamoxifen gel (a substance made when tamoxifen breaks down in the body) may be effective in reducing breast density by reducing estrogen levels with fewer side effec...
What is the current status of trial NCT00084344?
This trial is currently completed. It is a NA study. The study started on 2003-04. Estimated completion is 2004-07.
What interventions are being tested in trial NCT00084344?
The interventions under investigation include: breast imaging study (PROCEDURE), radiomammography (PROCEDURE), 4-hydroxytamoxifen (DRUG).
Who is sponsoring clinical trial NCT00084344?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.